These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2890366)

  • 1. Influence of "priming" on the potency of non-depolarizing neuromuscular blocking agents.
    Brady MM; Mirakhur RK; Gibson FM
    Br J Anaesth; 1987 Oct; 59(10):1245-9. PubMed ID: 2890366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cumulative and single bolus dose techniques for determining the potency of vecuronium.
    Gibson FM; Mirakhur RK; Clarke RS; Lavery GG
    Br J Anaesth; 1985 Nov; 57(11):1060-2. PubMed ID: 2864944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atracurium and vecuronium: effect of dose on the time of onset.
    Healy TE; Pugh ND; Kay B; Sivalingam T; Petts HV
    Br J Anaesth; 1986 Jun; 58(6):620-4. PubMed ID: 2871849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of vecuronium, atracurium and pancuronium in divided doses: effect on onset and duration of action.
    Brady MM; Mirakhur RK; Clarke RS
    Eur J Anaesthesiol; 1988 Jul; 5(4):243-9. PubMed ID: 2904367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromuscular blocking effects of atracurium, vecuronium and pancuronium during bolus and infusion administration.
    Gramstad L; Lilleaasen P
    Br J Anaesth; 1985 Nov; 57(11):1052-9. PubMed ID: 2864943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical comparison of atracurium and vecuronium (Org NC 45).
    Robertson EN; Booij LH; Fragen RJ; Crul JF
    Br J Anaesth; 1983 Feb; 55(2):125-9. PubMed ID: 6131682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated onset of non-depolarizing neuromuscular blocking drugs: pancuronium, atracurium and vecuronium. A comparison with succinylcholine.
    Mehta MP; Sokoll MD; Gergis SD
    Eur J Anaesthesiol; 1988 Jan; 5(1):15-21. PubMed ID: 2897912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Profile of the effect of succinylcholine after pre-curarization with atracurium, vecuronium or pancuronium].
    Ebeling BJ; Keienburg T; Hausmann D; Apffelstaedt C
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Jun; 31(5):304-8. PubMed ID: 8767244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vecuronium and d-tubocurarine combination: potentiation of effect.
    Mirakhur RK; Gibson FM; Ferres CJ
    Anesth Analg; 1985 Jul; 64(7):711-4. PubMed ID: 2861763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the neuromuscular and cardiovascular effects of pipecuronium, pancuronium, atracurium, and vecuronium under isoflurane anesthesia.
    Larijani GE; Gratz I; Minassian SS; Hughes DL; Afshar M; Karayannis BN
    Pharmacotherapy; 1992; 12(4):278-82. PubMed ID: 1355599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Train-of-four fade during onset of neuromuscular block with nondepolarising neuromuscular blocking agents.
    Gibson FM; Mirakhur RK
    Acta Anaesthesiol Scand; 1989 Apr; 33(3):204-6. PubMed ID: 2567104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atracurium, vecuronium and pancuronium in end-stage renal failure. Dose-response properties and interactions with azathioprine.
    Gramstad L
    Br J Anaesth; 1987 Aug; 59(8):995-1003. PubMed ID: 2888477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose-response curves for vecuronium during halothane and neurolept anaesthesia: single bolus versus cumulative method.
    Ording H; Skovgaard LT; Engbaek J; Viby-Mogensen J
    Acta Anaesthesiol Scand; 1985 Jan; 29(1):121-4. PubMed ID: 2858146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response relationships and neuromuscular blocking effects of vecuronium pancuronium during ketamine anaesthesia.
    Engbaek J; Ording H; Pedersen T; Viby-Mogensen J
    Br J Anaesth; 1984 Sep; 56(9):953-7. PubMed ID: 6147154
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose requirements of vecuronium, pancuronium, and atracurium during orthotopic liver transplantation.
    O'Kelly B; Jayais P; Veroli P; Lhuissier C; Ecoffey C
    Anesth Analg; 1991 Dec; 73(6):794-8. PubMed ID: 1683184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuromuscular and cardiovascular effects of pipecuronium.
    Foldes FF; Nagashima H; Nguyen HD; Duncalf D; Goldiner PL
    Can J Anaesth; 1990 Jul; 37(5):549-55. PubMed ID: 1973636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous infusions of atracurium and vecuronium, compared with intermittent boluses of pancuronium: dose requirements and reversal.
    Beattie WS; Buckley DN; Forrest JB
    Can J Anaesth; 1992 Nov; 39(9):925-31. PubMed ID: 1360337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atracurium: neuromuscular blockade in repeated administration].
    Kube D; Schuh FT
    Anaesthesist; 1985 Dec; 34(12):639-44. PubMed ID: 2869712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extending a pipecuronium neuromuscular block. Increments of atracurium or vecuronium as an alternative to pipecuronium.
    Roberts SP; Ramsay TM; Healy TE; Wilson A; Pollard BJ
    Anaesthesia; 1993 Mar; 48(3):196-9. PubMed ID: 8096370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.